Subject(s)
Atrial Flutter/diagnosis , Coronary Sinus/physiopathology , Electrophysiologic Techniques, Cardiac/methods , Tachycardia, Supraventricular/diagnosis , Atrial Fibrillation/surgery , Cardiac Catheterization , Cryosurgery , Electrocardiography , Humans , Male , Middle Aged , Tachycardia, Supraventricular/physiopathologySubject(s)
Electrophysiologic Techniques, Cardiac , Heart Ventricles , Pulmonary Valve , Adult , Artifacts , Catheter Ablation , Electrocardiography , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Heart Ventricles/surgery , Humans , Male , Pulmonary Valve/diagnostic imaging , Pulmonary Valve/physiopathology , Pulmonary Valve/surgery , Tachycardia, Ventricular/diagnostic imaging , Tachycardia, Ventricular/physiopathology , Tachycardia, Ventricular/surgery , Ventricular Premature Complexes/diagnostic imaging , Ventricular Premature Complexes/physiopathology , Ventricular Premature Complexes/surgeryABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Gastroparesis/diagnostic imaging , Gastroparesis/surgery , Cryosurgery/instrumentation , Pulmonary Veins/surgery , Cardiac Electrophysiology/methods , Anti-Arrhythmia Agents/therapeutic use , Gastroparesis/complications , Atrial Fibrillation/complications , Angiography/methods , Metoclopramide/therapeutic use , Erythromycin/therapeutic use , Radiography, Abdominal/methodsABSTRACT
Anticoagulation therapy is essential to reduce the risk of stroke in patients with atrial fibrillation. Traditionally, clinical trials have focused only on determining the efficacy and safety of anticoagulation but not on quality of life. In the last few years there has been a growing interest in determining the quality of life of patients treated with oral anticoagulation. In fact, specific tools that can evaluate quality of life related to atrial fibrillation and anticoagulation have been developed. Vitamin K antagonists have been shown to be effective in the prevention of thromboembolic complications. However, the use of vitamin K antagonists implies changes in behavior and lifestyle modifications that may have a negative impact on the quality of life. It has been suggested that self-monitoring of international normalized ratio could improve this impact. On the other hand, as new oral anticoagulants overcome these limitations, they may improve quality of life related with anticoagulant therapy. Unfortunately, although encouraging, the clinical experience with them is still quite limited.
